PROSPECT trial could provide new treatment options for some patients with rectal cancer
Thomas George, M.D., FACP, was a coauthor on the study presented at the ASCO Annual Meeting. UF Health participated in the multicenter study.
Posts tagged as
Thomas George
UF Health Cancer Center leaders honored as ASCO Advocacy Champions
Thomas George, M.D., FACP, and Merry Jennifer Markham, M.D., FACP, FASCO, were honored for exemplifying cancer care advocacy in 2022.
Neoadjuvant chemoradiation plus veliparib or pembrolizumab fails to improve NAR score in locally advanced rectal cancer
Thomas George, M.D., FACP, discussed findings from the phase 2 NRG-GI002 trial in an interview with OncLive at the ASCO GI Symposium.
Research Snapshot: UF study finds younger patients with colorectal cancer less likely to have targetable genetic mutations
Universal genetic testing at UF Health identified a relatively large population of older patients with sporadic colorectal cancer who were eligible for immunotherapy.
Thomas George, M.D., named Associate Director of Clinical Investigation
The UF Health Cancer Center is pleased to announce that Thomas George, M.D., F.A.C.P., has been appointed the center's associate director of clinical investigation.
